BRAF and melanoma: BRAF mutations occur in 40–50% of melanoma patients, whereas NRAS mutations are identified in additional 15–20% (Chin, 2003; Chin et al., 2006; Eigentler et al, 2016; Flaherty et al., 2012; Gonzalez et al., 2013; Tsao et al., 2012).